Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Hepatitis C virus research, Alcohol Consumption and Health Effects, and Liver Disease and Transplantation.
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort.
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.
Larsucosterol for the Treatment of Alcohol-Associated Hepatitis
“The alcohol-harm paradox”: Understanding socioeconomic inequalities in liver disease
Co-existing regeneration mechanisms in severe alcohol-related steatohepatitis.
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.
Novel interventions against alcohol-related liver disease.
Risk factors associated with liver-related complications in diabetes: There may be more than meets the eye.
Duodenal organoids from metabolic dysfunction-associated steatohepatitis patients exhibit altered digestive homeostasis
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study
Evolution in diagnosis and management of chronic liver diseases.
The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
Management of alcohol‐related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers
Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver Disease
Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification
Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis